Background: Primary cutaneous aspergillosis is an uncommon finding in patients with acquired immunodeficiency syndrome (AIDS); only 13 cases have been reported in the literature.
Observations: We describe 11 patients with primary cutaneous aspergillosis and AIDS. There does not seem to be an age, sex, race, or human immunodeficiency virus risk factor predisposition. This is a late manifestation of AIDS; patients typically have low CD4 counts (<0.050 x 10(9)/L [<50/microL]) and other AIDS-defining illnesses. The most frequent presentation is in patients with cytomegalovirus disease and neutropenia caused by ganciclovir therapy. Lesions developed at the site of occlusive dressings for an indwelling intravenous catheter site in 10 patients. Neutrophil counts may be normal at the time of diagnosis. A minor presentation is in the patient without neutropenia as a result of traumatic inoculation. Histological findings and/or culture results are required for diagnosis. Patients develop cutaneous lesions despite prophylactic therapy with fluconazole. Lesions can be treated with excision and lifelong therapy with itraconazole.
Conclusion: Because of the potential morbidity and mortality of cutaneous aspergillosis, a high level of suspicion and prompt institution of therapy is required.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archderm.136.3.365 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Break through the mold: Hyper-IgE syndrome as a vehicle for invasive aspergillosis.
Respir Med Case Rep
December 2024
Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Hyperimmunoglobulin E syndrome (HIGES) is a rare immunodeficiency characterized by high levels of immunoglobulin E (IgE) in the setting of various clinical features such as cutaneous candidiasis, asthma, recurrent rashes, and fungal infections. This case describes a 70-year-old male with cachexia and dyspnea found to have a cavitary lesion and aspergilloma, with remarkably high IgE and positive 1,3-β-D-glucan and Aspergillus testing. Herein, we describe the aforementioned case, review the available literature, and hypothesize the connection between invasive fungal infections and HIGES.
View Article and Find Full Text PDFAspergillus spondylodiscitis successfully treated with a long course of isavuconazole.
J Infect Chemother
February 2025
Infectious Diseases Department, Ramón y Cajal University Hospital, Madrid, Spain; University of Alcalá, IRYCIS, CIBERINFEC, Spain.
Article Synopsis
- A case of spondylodiscitis caused by Aspergillus fumigatus was successfully treated with isavuconazole after the patient showed severe intolerance to the standard treatment, voriconazole.
- Isavuconazole is a newer antifungal that has been shown to be just as effective as voriconazole for invasive aspergillosis, with fewer side effects and no need for serum level monitoring.
- While current research on isavuconazole specifically for spondylodiscitis is limited, this case adds to the evidence supporting its use in treating this serious condition.
Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology.
J Clin Microbiol
December 2024
Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Article Synopsis
[An invasive cutaneous aspergillosis during a granulomatosis with polyangiitis].
Rev Med Interne
November 2024
Service de médecine interne, CHU de Saint-Étienne, hôpital Nord, Saint-Étienne, France. Electronic address:
Article Synopsis
- - Aspergillosis is a serious infection that can occur in individuals with weakened immune systems, primarily affecting the lungs but sometimes spreading to the skin and other areas in severe cases.
- - A 76-year-old woman with a relapse of a certain autoimmune disease and undergoing immunosuppressive treatment developed skin lesions, which were diagnosed as invasive cutaneous aspergillosis through a biopsy.
- - The patient improved significantly after being treated with voriconazole, highlighting the importance of thorough testing for opportunistic infections in immunocompromised patients presenting with unusual skin symptoms.
Management of anti-melanoma differentiation-associated gene 5 antibody-induced refractory dermatomyositis complicated by interstitial pneumonia using tofacitinib and its outcomes: a case report.
J Med Case Rep
September 2024
Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, minami1-nishi16Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.
Article Synopsis
- Clinical amyopathic dermatomyositis is a skin condition that lacks muscle symptoms and is often associated with anti-melanoma differentiation-associated gene 5 antibodies, particularly in Japanese patients, leading to poor outcomes in those with lung complications.
- A 52-year-old male presented with severe respiratory issues and skin rashes, diagnosed with dermatomyositis-related interstitial pneumonia, but treatment with steroids and immunosuppressants was largely ineffective.
- Despite some initial improvement after switching medications, the patient ultimately faced worsening respiratory failure due to invasive pulmonary aspergillosis, resulting in a fatal outcome.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!